| May 7, 2009: Dr. Magnus E. Ohman presents Optimal Upstream Anti-Thrombin Therapy | |
|
Dr. Magnus E. Ohman presents Optimal Upstream Anti-Thrombin Therapy at the 2009 SCAI Scientific Sessions in Las Vegas. Research Grants -Sanofi-Aventis, Schering-Plough, Eli Lilly, Daiichi-Sankyo, Bristol-Myers Squibb, CV Therapeutics, Datascope, and the Medicines Company Stock Ownership -Inovise Consultant -Response Biomedical, Northpoint Domain, CV Therapeutics, The Medicines Company, Abiomed, Datascope, Liposcience and Inovise Medical [ Download video ] |
Get the Flash Player to see this player. |